Skip to main content
. 2025 Apr 16;15:1547376. doi: 10.3389/fcimb.2025.1547376

Table 1.

Composition of lipids and drugs used in formulation preparation.

Formulation Drug DOPCE (mg) Cholesterol (mg) DSPE-mPEG-2000 (mg) PBS (mL)
[R4W4] Liposomes 400 (μg) 25 7 10 10
Rifampicin Liposomes 5 (mg) 25 7 10 10
Azithromycin Liposomes 2 (mg) 25 7 10 10
Peptide-Rifampicin Liposomes 400 (μg)/5 (mg) 25 7 10 10
Peptide-Azithromycin Liposomes 400(μg)/2 (mg) 25 7 10 10
Blank Liposome No drug/peptide 25 7 10 10